Wegovy Side Effects: Blood Clots, DVTs, and Pulmonary Embolisms Wegovy is a semaglutide used to reduce the risk of major cardiovascular events in adults with obesity or who are overweight and to help adults and children 12 years and older with obesity or who are overweight with a weight-related medical problem
Diabetic patients should also be aware that the HbA1c impact of semaglutide, while substantial, may not fully match what they achieved on tirzepatide, particularly at higher tirzepatide doses
Stress triggers the release of cortisol, which in turn reduces the production of GLP-1
A personalized program ensures that you are not just taking a popular medication, but the one that aligns with your bodys needs
Maintain consistent use daily for best results
When Virta member Tiffinnie learned she had prediabetes, she at first took a kitchen-sink approach to reversing it